Serra Ozbal Gunes

Serra Ozbal Gunes

Auto-generated profile, based on publicly available information

Serra Ozbal Gunes

Department of Radiology, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2020 in Diagnostic and Interventional Radiology
Verified
Journal Article
Closed access
AGAltan Gunes
Altan Gunes
SGSerra Ozbal Gunes
Serra Ozbal Gunes
PURPOSE We aimed to evaluate the frequency and neuroimaging features of Rathke's cleft cysts (RCCs) in children examined for endocrine-related diseases and to determine changes in the neuroimaging features of RCCs during the follow-up of children. We hypothesize that RCCs are being more commonly diagnosed in children with endocrine-related diseases and most of the RCCs show neither fluid intensity nor intensity due to high protein content on magnetic resonance imaging (MRI). METHODS After approval by the local ethics committee, the medical records and contrast-enhanced pituitary MRI of 833 children (boys/girls, 338/495; mean age±SD, 9.4±3.7 years) were retrospectively reviewed between January 2016 and January 2019. The size, location, signal intensities, and postcontrast enhancement pattern of RCCs were assessed by a pediatric radiologist. Same imaging features were also independently reviewed by another radiologist to determine the interobserver agreement by using the kappa statistics (κ) and intraclass correlation coefficient (ICC). RESULTS RCC was evident on MRI in 13.5% of the patients (boys/girls, 39/74; mean age±SD, 9.8±3.9 years). The mean size of RCCs was 5.5 mm (range, 3.1-8.5 mm). An RCC frequency higher than expected was found in patients with central precocious puberty, diabetes insipidus, and hypersecretion of prolactin (P = 0.007). The mean size of RCCs did not show significant differences among the clinical indications for MRI (P ≥ 0.461). All RCCs showed abnormal signal on T2-weighted image and most (89%) showed neither fluid intensity nor intensity due to high protein content (i.e., isointense on T1-weighted imaging and hypointense on T2-weighted imaging compared with the normal anterior pituitary gland). Eighty-four patients with RCCs (74%) had follow-up MRI and the mean follow-up was 1.5 years. In follow-ups, five RCCs disappeared; the mean size of 10 RCCs increased and that of 6 RCCs decreased. These size changes were not statistically significant (P = 0.376). No signal intensity changes of RCCs were seen during the follow-up, except for 4 RCCs, whose protein content increased over time and T1 signals increased on imaging. Interobserver agreements were almost perfect for the MRI findings of RCCs (κ and ICC range, 0.81-1, P < 0.001). CONCLUSION RCCs were not uncommon in patients examined for endocrine-related diseases, and nearly 1 in 10 patients had an RCC. The size and signal intensities of RCCs may change over time and the evolution of RCCs is unpredictable. Most RCCs showed neither fluid intensity nor intensity due to high protein content on MRI, and all RCCs had an abnormal signal on T2-weighted imaging, thus eliminating the need to administer a contrast agent at follow-up imaging of the patients.

1 November 2021 in Clinical Imaging
Verified
Journal Article
Closed access
SGSerra Ozbal Gunes
Serra Ozbal Gunes
YAYeliz Akturk
Yeliz Akturk
EGEsra Soyer Guldogan
Esra Soyer Guldogan
KYKerim Bora Yilmaz
Kerim Bora Yilmaz
OEOnur Ergun
Onur Ergun
BHBaki Hekimoglu
Baki Hekimoglu

16 November 2017 in Japanese Journal of Radiology
Verified
Journal Article
Closed access
PDF file
SGSerra Ozbal Gunes
Serra Ozbal Gunes
YAYeliz Akturk
Yeliz Akturk

Verified
Journal Article
Open access
PDF file
SSSercan Sarı
Sercan Sarı
MÇMehmet Çağlar Çakıcı
Mehmet Çağlar Çakıcı
İKİbrahim Kartal
İbrahim Kartal
VSVOLKAN SELMI
VOLKAN SELMI
HÖHarun Özdemir
Harun Özdemir
HEHamit Ersoy
Hamit Ersoy
Objectives: Holmium:Yttrium Aluminum Garnet laser lithotripsy is used in Retrograde Intrarenal Surgery. Fragmentation is made with a certain value of pulse energy (Joule) and frequency (Hertz) in Holmium laser lithotripsy and the multiplication of these values gives us total power (Watt). Devices with maximum power of 20 Watt and 30 Watt are used in clinical practice. We want to compare the efficiency, safety and pain scores of the lithotripsy made below 20 Watt and over 30 Watt with 30 Watt laser device. Materials and methods: 60 patients who had 2-3 cm sized kidney stones and operation planned were prospectively divided into three groups. Groups were random identified. In the first group, fragmentation was performed below 20 Watt power with 20 Watt laser device. In the second group, fragmentation was performed below 20 Watt power with 30 Watt laser device. In the third group, fragmentation was performed over 20 Watt power with 30 Watt laser device. Demographic, stone, intraoperative and postoperative data were recorded. We compared these groups regarding efficiency, safety and pain score.Results: For demographic and stone data, there was a statistically significant difference only for stone number. For intraoperative and postoperative data, there was a statistically significant difference only for ureteral access sheath usage between the groups. Success was lower than the other groups in Group 1.Conclusions: Success was higher in groups using 30 Watt laser device. There was not statistically significantly difference between complications and pain. 30 Watt laser device is safe and efficient in Retrograde Intrarenal Surgery.

31 August 2022 in Turkish Archives of Otorhinolaryngology
Verified
Journal Article
Open access
VYVolkan Yücel
Volkan Yücel
SGSerra Özbal Güneş
Serra Özbal Güneş
KKKemal Keseroğlu
Kemal Keseroğlu
ÖBÖmer Bayır
Ömer Bayır
MÇMehmet Furkan Çırakoğlu
Mehmet Furkan Çırakoğlu
MKMehmet Hakan Korkmaz
Mehmet Hakan Korkmaz
To investigate the prognostic value of the magnetic resonance imaging in Bell’s palsy patients. Patients who were diagnosed and treated with Bell’s palsy between October 2013 and March 2016 retrospectively selected. House–Brackmann grades, pre- and post-treatment pure tone audiograms, stapedial reflexes were analyzed and magnetic resonance imaging (MRI) scans with gadolinium-based contrast agents were evaluated. Contrast-enhanced segments of the facial nerve were determined. MRI findings were compared statistically with pre- and post-treatment grade, recurrence rate of Bell’s palsy, MRI scanning timing, presence of stapes reflexes and posttreatment recovery data. No significant correlation was observed between pretreatment House–Brackmann grades and enhancement (p>0.05). Similarly, there was no significant correlation between clinical recovery and enhancement (p>0.05). Also, no significant correlation was observed between MRI scanning time, the recurrence rate of Bell’s palsy and MRI findings (p>0.05). None of the MRIs showed neoplastic contrast enhancement. The routine use of the contrast-enhanced temporal MRI is not recommended in the diagnosis and monitoring of Bell’s palsy patients, because the contrast enhancement pattern of the facial nerve has no effect on the prognosis of Bell’s palsy. MRI should be used in cases that do not heal despite treatment, for the differential diagnosis of facial nerve tumors and in patients who are candidates for surgical decompression.

16 April 2021 in International Journal Of Clinical Practice
Verified
Journal Article
Closed access
PDF file
NKNihat Karakoyunlu
Nihat Karakoyunlu
MÇMehmet Çağlar Çakıcı
Mehmet Çağlar Çakıcı
SSSercan Sarı
Sercan Sarı
EHEmre Hepşen
Emre Hepşen
MBMuslim Bikirov
Muslim Bikirov
HEHamit Ersoy
Hamit Ersoy
Aims To compare the efficacy of different laser devices and power ranges on lithotripsy in retrograde intrarenal surgery (RIRS) for 1‐2 cm kidney stones. Methods A total of 223 participants undergoing RIRS for 1‐2 cm kidney stones at our clinic between January 2015 and January 2017 were recruited for this prospective study (NCT02451319). Two hundred and four participants included in our study were randomly allocated into either ≤20 W with 20 W laser device (group 1) or ≤20 W with 30 W laser device (group 2) or >20 W with 30 W laser device (group 3). Results There was no significant difference between the groups in terms of demographic and stone characteristics. Operation and fluoroscopy times were significantly longer (P = .003 and P < .001, respectively) and stone‐free rate (SFR) was significantly lower in group 1 (P = .002). Complications were similar in all three groups (P = .512). However, post‐operative pain scores were significantly higher in group 1 (P < .001). The multivariate analysis revealed that stone size (95% CI: 0.654‐0.878, OR = 0.758, P < .001), ureteral access sheath use (95% CI: 1.003‐20.725, OR = 4.560, P = .049), and lithotripsy with 30 W laser device (95% CI: 1.304‐11.632, OR = 3.895, P = .015; 95% CI: 1.738‐17.281, OR = 5.480, P = .004, groups 2 and 3, respectively) were independent factors predicting SFR for RIRS used in 1‐2 cm kidney stones. Conclusion The 30 W laser device used in RIRS for 1‐2 cm kidney stones had shorter operation times, higher SFRs, and lower post‐operative pain scores compared with the 20 W device. The 30 W laser device is safe and more efficient in RIRS for treatment of 1‐2 cm kidney stones.